tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Compare Spyre Therapeutics (SYRE) vs. Competitors

535 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Spyre Therapeutics
$63.27
$4.03B
-45.32
417.76%
16 Buy
0 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$14.52
$1.18B
-5.77
169.89%
10 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$317.00
$8.80B
-21.87
965.90%
14 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$8.30
$799.34M
-6.70
-43.06%
3 Buy
0 Hold
0 Sell
Strong Buy
Oculis Holding
$27.12
$1.56B
-8.77
61.91%
5 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$30.30
$570.87M
-10.19
38.81%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SYRE
Spyre Therapeutics
63.27
50.56
397.80%
EYPT
EyePoint Pharmaceuticals
14.52
8.85
156.08%
PRAX
Praxis Precision Medicines
317.00
287.33
968.42%
SPRY
ARS Pharmaceuticals
8.00
-6.99
-46.63%
OCS
Oculis Holding
27.12
9.19
51.25%
UPB
Upstream Bio, Inc.
10.23
2.46
31.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts